Skip to main content
. 2018 Oct 3;2(19):2513–2521. doi: 10.1182/bloodadvances.2017010744

Figure 6.

Figure 6.

Nonoverlapping mutations are significantly enriched in de novo AML. Each dot represents the number of blast-specific nonoverlapping mutations in each patient. Green asterisks indicate mutations detected in NPM1-AML. *P < .05, **P < .01.